BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33058355)

  • 1. Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease.
    Zhang Y; Zhang Z; Li L; Xu K; Ma Z; Chow HM; Herrup K; Li J
    FASEB J; 2020 Dec; 34(12):16364-16382. PubMed ID: 33058355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
    Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M
    Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease.
    Phipps AJ; Vickers JC; Taberlay PC; Woodhouse A
    Neurobiol Aging; 2016 Sep; 45():30-42. PubMed ID: 27459923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
    Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
    Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Resolution Analysis of 5-Hydroxymethylcytosine by TET-Assisted Bisulfite Sequencing.
    Huang Z; Meng Y; Szabó PE; Kohli RM; Pfeifer GP
    Methods Mol Biol; 2021; 2198():321-331. PubMed ID: 32822042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA.
    Skvortsova K; Zotenko E; Luu PL; Gould CM; Nair SS; Clark SJ; Stirzaker C
    Epigenetics Chromatin; 2017; 10():16. PubMed ID: 28428825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer's disease.
    Shu L; Sun W; Li L; Xu Z; Lin L; Xie P; Shen H; Huang L; Xu Q; Jin P; Li X
    BMC Genomics; 2016 May; 17():381. PubMed ID: 27207465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease.
    Qin L; Xu Q; Li Z; Chen L; Li Y; Yang N; Liu Z; Guo J; Shen L; Allen EG; Chen C; Ma C; Wu H; Zhu X; Jin P; Tang B
    Hum Mol Genet; 2020 Jan; 29(1):149-158. PubMed ID: 31814020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds.
    Cao D; Jiang D; Zhou D; Yu H; Li J
    Biomed Res Int; 2020; 2020():5016706. PubMed ID: 32802849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine.
    Efimova OA; Koltsova AS; Krapivin MI; Tikhonov AV; Pendina AA
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint single-cell profiling resolves 5mC and 5hmC and reveals their distinct gene regulatory effects.
    Fabyanic EB; Hu P; Qiu Q; Berríos KN; Connolly DR; Wang T; Flournoy J; Zhou Z; Kohli RM; Wu H
    Nat Biotechnol; 2024 Jun; 42(6):960-974. PubMed ID: 37640946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Tet2 exacerbates early stage Alzheimer's pathology and cognitive impairments in 2×Tg-AD mice.
    Li L; Qiu Y; Miao M; Liu Z; Li W; Zhu Y; Wang Q
    Hum Mol Genet; 2020 Jul; 29(11):1833-1852. PubMed ID: 31943063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease.
    Fetahu IS; Ma D; Rabidou K; Argueta C; Smith M; Liu H; Wu F; Shi YG
    Sci Adv; 2019 Aug; 5(8):eaaw2880. PubMed ID: 31489368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related epigenome-wide DNA methylation and hydroxymethylation in longitudinal mouse blood.
    Kochmanski J; Marchlewicz EH; Cavalcante RG; Sartor MA; Dolinoy DC
    Epigenetics; 2018; 13(7):779-792. PubMed ID: 30079798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
    Armstrong MJ; Jin Y; Vattathil SM; Huang Y; Schroeder JP; Bennet DA; Qin ZS; Wingo TS; Jin P
    Neurobiol Dis; 2023 Sep; 185():106257. PubMed ID: 37562656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic distribution and possible functions of DNA hydroxymethylation in the brain.
    Wen L; Tang F
    Genomics; 2014 Nov; 104(5):341-6. PubMed ID: 25205307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus.
    Chen H; Dzitoyeva S; Manev H
    Restor Neurol Neurosci; 2012; 30(3):237-45. PubMed ID: 22426040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlated 5-Hydroxymethylcytosine (5hmC) and Gene Expression Profiles Underpin Gene and Organ-Specific Epigenetic Regulation in Adult Mouse Brain and Liver.
    Lin IH; Chen YF; Hsu MT
    PLoS One; 2017; 12(1):e0170779. PubMed ID: 28125731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
    J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers.
    Wang Z; Du M; Yuan Q; Guo Y; Hutchinson JN; Su L; Zheng Y; Wang J; Mucci LA; Lin X; Hou L; Christiani DC
    Neoplasia; 2020 Mar; 22(3):154-161. PubMed ID: 32062069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.